V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Debut trading of Achilles Therapeutics, Inc.

01.04.2021

In its debut trading on Wednesday, March 31 Achilles Therapeutics, Inc. (ACHL) decreased 8.06% and closed at $16.55 per share. Shortly before the company had placed its shares in IPO priced $18 per share.